India, March 28 -- Shares of DBV Technologies S.A. (DBVT) jumped over 38% on Friday after the company announced financing of up to $306.9 million or 284.5 million euros.
DBVT is currently trading at $5.62, up $1.57 or 38.77%, on a volume of 20 million shares, above average volume of 62 thousand, on the Nasdaq. The stock opened its trading at $6.05 after closing Thursday at $4.05. The stock has traded between $0.44 and $6.78 in the past 52-week period.
DBV Technologies, a clinical-stage biopharmaceutical company dedicated to treating pediatric allergies, announced a financing of up to $306.9 million, including gross proceeds of $125.5 million to be received upon closing and an aggregate of up to $181.4 million in gross proceeds if all the ...